Anti Virus Trial Page

Dr. Márquez often told her students: “A trial isn’t a success because the drug works. It’s a success because we honestly learn what it can and cannot do—and we tell the truth about both.”

With regulatory approval, 40 healthy volunteers received ascending doses of AVI-7 at a hospital in Oslo. The goal: find side effects. Most reported mild nausea. Two developed temporary liver enzyme elevations, setting a maximum safe dose. No one died. No one got sick from the virus because they were never exposed to it. anti virus trial

The trial that followed was a masterclass in scientific caution and ethics. anti virus trial